Manic switches induced by antidepressants: an umbrella review comparing randomized controlled trials and observational studies

Acta Psychiatrica Scandinavica

Volumn 135, Issue 2, 2017, Pages 106-116

  Allain, N ^a,b   Leven, C ^c,d   Falissard, B ^e   Allain, J S ^a   Batail, J M ^a,b   Polard, E ^a   Montastruc, F ^f   Drapier, D ^a,b   Naudet, F ^d,g  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b Behavior and Basal Ganglia Unit EA 4712 University of Rennes 1   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

^d UNIVERSITÉ DE RENNES 1   (France)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^f Faculté de Médecine Centre Hospitalo universitaire   (France)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

affective disorders; depression; meta analysis; randomized controlled trial

Indexed keywords

ANTIDEPRESSANT AGENT; IMIPRAMINE; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BIPOLAR DISORDER; COCHRANE LIBRARY; EMBASE; HUMAN; MAJOR DEPRESSION; MANIA; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; ADULT; CHILD; CLASSIFICATION; COMPARATIVE STUDY; DEPRESSIVE DISORDER, MAJOR; FEMALE; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; PRESCHOOL CHILD; REGRESSION ANALYSIS;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CHILD; CHILD, PRESCHOOL; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS;

EID: 85006059592     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12672     Document Type: Article

References (30)

1. Gøtzsche P, Young A, Crace J. Does long term use of psychiatric drugs cause more harm than good? BMJ 2015;350:h2435.
2. Gøtzsche P. Why I think antidepressants cause more harm than good. Lancet Psychiatry 2014;1:104–106.
3. Nutt DJ, Goodwin GM, Bhugra D, Fazel S, Lawrie S. Attacks on antidepressants: signs of deep-seated stigma? Lancet Psychiatry 2014;1:102–104.
4. Naudet F, Falissard B. Antipsychiatry and the antidepressants debate. Lancet Psychiatry 2014;1:173–174.
5. Ioannidis J. Adverse events in randomized trials: neglected, restricted, distorted, and silenced. Arch Intern Med 2009;169:1737–1739.
6. Pitrou I, Boutron I, Ahmad N, Ravaud P. Reporting of safety results in published reports of randomized controlled trials. Arch Intern Med 2009;169:1956–1961.
7. Tang E, Ravaud P, Riveros C, Perrodeau E, Dechartres A. Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles. BMC Med 2015;13:189.
8. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet Lond Engl 2000;356:1255–1259.
9. Thomas SJ, Shin M, McInnis MG, Bostwick JR. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression. Pharmacotherapy 2015;35:433–449.
10. The Joanna Briggs Institute: Joanna Briggs Institute Reviewers’ Manual, 2011. Available from: http://joannabriggs.org/assets/docs/sumari/ReviewersManual-2011.pdf
11. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2, 2008. Available from: http://www.cochrane-handbook.org
12. Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
13. Martin A, Young C, Leckman JF, Mukonoweshuro C, Rosenheck R, Leslie D. Age effects on antidepressant-induced manic conversion. Arch Pediatr Adolesc Med 2004;158:773–780.
14. Truman CJ, Goldberg JF, Ghaemi SN et al. Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 2007;68:1472–1479.
15. Post RM, Altshuler LL, Leverich GS et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006;189:124–131.
16. Shirazi E, Alaghband-Rad J. An open trial of citalopram in children and adolescents with depression. J Child Adolesc Psychopharmacol 2005;15:233–239.
17. Tondo L, Vázquez G, Baldessarini RJ. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand 2010;121:404–414.
18. Goldberg J, Whiteside J. The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J Clin Psychiatry 2002;63:791–795.
19. Baldessarini RJ, Faedda GL, Offidani E et al. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord 2013;148:129–135.
20. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry J Ment Sci 1994;164:549–550.
21. Keup W, Apolito A, Olinger L, Schwartz M, Yachnes E. Inpatient treatment of depressive states with tofranil (imipramine hydrochloride). Am J Psychiatry 1959;116:257–258.
22. Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007;356:1711–1722.
23. Keller MB, Ryan ND, Strober M et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40:762–772.
24. Canadian Medical Association or its licensors. Drug company experts advised staff to withhold data about SSRI use in children. CMAJ 2004;170:783.
25. Noury JL, Nardo JM, Healy D et al. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 2015;351:h432027.
26. Avorn J. Two centuries of assessing drug risks. N Engl J Med 2012;367:193–197.
27. Healy D, Bechthold K, Tolias P. Antidepressant-induced suicidality: how translational epidemiology incorporating pharmacogenetics into controlled trials can improve clinical care. Pers Med 2014;11:79–88.
28. Naudet F, Maria AS, Falissard B. Antidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studies. PLoS ONE 2011;6:e20811.
29. Van der Lem R, Van der Wee NJA, Van Veen T, Zitman FG. Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice. Psychother Psychosom 2012;81:226–234.
30. Naudet F, Falissard B, Boussageon R, Healy D. Has evidence-based medicine left quackery behind? Intern Emerg Med 2015;10:631–634.